News
22h
Stocktwits on MSNJohnson & Johnson Submits Supplemental Drug Application To FDA For Schizophrenia Drug CaplytaJohnson & Johnson (JNJ) said on Tuesday that it has submitted a supplemental new drug application to the U.S. Food and Drug ...
Pharma Vet brings 20+ years of Legal, Compliance, and Commercialization Expertise as Company prepares ADHD Drug Filing ...
- NDA assigned a Target Action Date of February 25, 2026 - ...
The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.
While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers ...
Cogent Biosciences Shares Rise After Mastocytosis Treatment Reaches Primary Endpoint in Recent Study
Shares of Cogent Biosciences were higher after the company disclosed what it called positive top-line results from a recent trial of its treatment for certain types of mastocytosis, a rare disorder in ...
Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on ...
Phase 1/2a clinical trial currently supported by a $3.0 million grant from the U.S. Department of Defense Trial will enroll children with high grade glioma and ependymoma HOUSTON, June 25, 2025 (GLOBE ...
Shares of Instil Bio jumped after federal regulators cleared the investigational new drug application for its tumor treatment AXN-2510. The stock was up 11% at $24.38 in early trading. Shares were ...
Novo Nordisk NOVO.B0.25%increase; green up pointing triangle said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results